EuBiologics Co., Ltd. (206650.KQ)
KRW 12130.0
(-3.58%)
KRW 12130.0
(-3.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 26.45 Billion | 6.44 Billion | -7.6 Billion | -913.53 Million | 12.87 Billion | 2.93 Billion |
| Net Income | -13.87 Billion | -1.09 Billion | -27.57 Billion | -60.13 Billion | -881.62 Million | 3.78 Billion |
| Depreciation & Amortization | 9.16 Billion | 7.88 Billion | 6.56 Billion | 5.94 Billion | 2.97 Billion | 1.95 Billion |
| Deferred income taxes | -18.63 Billion | 4.84 Billion | 5.73 Billion | 3.27 Billion | - | - |
| Stock-based compensation | 777.07 Million | 4.03 Billion | 1.99 Billion | 346.27 Million | - | - |
| Change in working capital | 7.24 Billion | -6.78 Billion | -8.92 Billion | 1.41 Billion | 1.72 Billion | -5.07 Billion |
| Other non-cash items | 42.96 Billion | 28.95 Billion | 42.04 Billion | 68.78 Billion | 17.23 Billion | 9.28 Billion |
| Investing Cash Flow | -28.1 Billion | -2.13 Billion | -38.24 Billion | -15.24 Billion | -23.66 Billion | -34.76 Billion |
| Investments in PPE | -43.65 Billion | -30.87 Billion | -9.15 Billion | -9.93 Billion | -27.67 Billion | -24.75 Billion |
| Acquisitions | 89 Million | 5.63 Billion | 290.51 Thousand | 5 Million | 1.45 Million | - |
| Investment purchases | -208.1 Million | -25.15 Billion | -64.59 Billion | -4.49 Billion | -3 Billion | -49.08 Billion |
| Sales/Maturities of investments | 217.5 Million | 48 Billion | 36.29 Billion | - | 8 Billion | 39.48 Billion |
| Other Investing Activities | 15.44 Billion | 258.91 Million | -788.76 Million | -812.21 Million | -994.22 Million | -411.21 Million |
| Financing Cash Flow | 566.02 Million | 634.58 Million | -712.6 Million | 63.58 Billion | 5.13 Billion | 33.42 Billion |
| Debt repayment | -2.26 Billion | -7.17 Billion | -2.3 Billion | -8.5 Billion | -3.51 Billion | -29.05 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -11.65 Million | - | - | - |
| Common Stock Issuance | 61.85 Million | 1.09 Billion | 1.32 Billion | 53.06 Billion | 671.8 Million | 3.48 Billion |
| Other Financing Activities | -728.41 Million | 717.3 Million | 1.04 Billion | 2.67 Billion | 1.46 Billion | 888.7 Million |
| Accounts receivables | -4.24 Billion | -622.62 Million | -1.02 Billion | -3.29 Billion | 758.16 Million | -2.33 Billion |
| Accounts payables | -220.46 Million | 548.02 Million | -405.95 Million | -96.77 Million | 139.97 Million | -74.82 Million |
| Inventory | 3.75 Billion | -6.67 Billion | -5.15 Billion | -1.64 Billion | -3.12 Billion | -683.7 Million |
| Other working capital | 7.96 Billion | -27.46 Million | -2.34 Billion | 6.45 Billion | 3.95 Billion | -1.98 Billion |
| Cash at beginning of period | 11.04 Billion | 6.53 Billion | 53.08 Billion | 5.66 Billion | 11.35 Billion | 9.64 Billion |
| Cash at end of period | 9.89 Billion | 11.04 Billion | 6.53 Billion | 53.08 Billion | 5.66 Billion | 11.35 Billion |
| Capital Expenditure | -43.65 Billion | -30.87 Billion | -9.15 Billion | -9.93 Billion | -27.67 Billion | -24.75 Billion |
| Effect of forex changes on cash | -54.89 Million | -432.87 Million | 4.52 Million | -1.9 Million | -35.46 Million | - |
| Net cash flow / Change in cash | -1.14 Billion | 4.5 Billion | -46.55 Billion | 47.42 Billion | -5.68 Billion | 1.71 Billion |
| Free Cash Flow | -17.2 Billion | -24.43 Billion | -16.76 Billion | -10.85 Billion | -14.79 Billion | -21.81 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.59 Billion | -3.61 Billion | -12.7 Billion | -13.87 Billion | -3.1 Billion | 2.03 Billion |
| Depreciation & Amortization | 2.29 Billion | 2.29 Billion | 2.34 Billion | 9.16 Billion | 2.35 Billion | 2.33 Billion |
| Deferred income taxes | - | - | -6.93 Billion | -18.63 Billion | -6.37 Billion | 1.09 Billion |
| Stock-based compensation | - | 507.47 Million | 541.81 Million | 777.07 Million | 458.56 Million | -1.05 Billion |
| Change in working capital | -2.36 Billion | 2.14 Billion | -3.98 Billion | 7.24 Billion | 8.67 Billion | 7.24 Billion |
| Other non-cash items | 5.89 Billion | 8.59 Billion | 29.54 Billion | 42.96 Billion | -2.41 Billion | 4.39 Billion |
| Investing Cash Flow | -2.59 Billion | -2.31 Billion | -6.3 Billion | -28.1 Billion | -7.19 Billion | -11.36 Billion |
| Investments in PPE | -3.48 Billion | -2.07 Billion | -8.4 Billion | -43.65 Billion | -8.03 Billion | -23.68 Billion |
| Acquisitions | 1.3 Million | - | 49 Million | 89 Million | - | - |
| Investment purchases | -52.02 Million | -52.02 Million | -52.02 Million | -208.1 Million | -52.02 Million | -52.02 Million |
| Sales/Maturities of investments | - | - | - | 217.5 Million | - | 10 Million |
| Other Investing Activities | 948.57 Million | -183.45 Million | 2.1 Billion | 15.44 Billion | 891.54 Million | 12.36 Billion |
| Financing Cash Flow | -402.44 Million | -304.97 Million | -182.66 Million | 566.02 Million | -180.67 Million | 735.92 Million |
| Debt repayment | -200 Million | -183 Million | -2.37 Billion | -2.26 Billion | -146 Million | -39.3 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 183.18 Million | - | - | 61.85 Million | 61.85 Million | - |
| Other Financing Activities | 24.24 Million | 29.09 Million | -2.45 Billion | -728.41 Million | 54.85 Million | 1.07 Billion |
| Accounts receivables | 2.46 Billion | 4.33 Billion | -4.57 Billion | -4.24 Billion | 8.31 Billion | -2.15 Billion |
| Accounts payables | -644.91 Million | 580.89 Million | 114.44 Million | -220.46 Million | 170.64 Million | -51.41 Million |
| Inventory | -4.03 Billion | -2.65 Billion | 2.45 Billion | 3.75 Billion | -749.43 Million | 1.5 Billion |
| Other working capital | -142.44 Million | -119.87 Million | -1.97 Billion | 7.96 Billion | 943.87 Million | 7.93 Billion |
| Cash at beginning of period | 14.46 Billion | 9.89 Billion | 7.98 Billion | 11.04 Billion | 6.8 Billion | 6.85 Billion |
| Cash at end of period | 8.99 Billion | 14.46 Billion | 9.89 Billion | 9.89 Billion | 7.98 Billion | 6.8 Billion |
| Capital Expenditure | -3.48 Billion | -2.07 Billion | -8.4 Billion | -43.65 Billion | -8.03 Billion | -23.68 Billion |
| Effect of forex changes on cash | - | 99.96 Million | -97.49 Million | -54.89 Million | 5.11 Million | -70.38 Million |
| Net cash flow / Change in cash | -5.47 Billion | 4.56 Billion | 1.91 Billion | -1.14 Billion | 1.17 Billion | -50.71 Million |
| Free Cash Flow | -6.06 Billion | 5 Billion | 95.87 Million | -17.2 Billion | 509.79 Million | -13.04 Billion |
BFAM
ZUO
NGI
KNG
603079
1438